Iron Triangle Partners LP - Q1 2022 holdings

$841 Million is the total value of Iron Triangle Partners LP's 28 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 41.7% .

 Value Shares↓ Weighting
ABBV SellABBVIE INC$38,906,000
+14.9%
240,000
-4.0%
4.63%
-1.9%
ACHC SellACADIA HEALTHCARE COMPANY IN$32,938,000
-14.2%
502,640
-20.5%
3.92%
-26.7%
NSTG SellNANOSTRING TECHNOLOGIES INC$25,103,000
-20.7%
722,395
-3.7%
2.99%
-32.3%
SGRY SellSURGERY PARTNERS INC$22,020,000
-24.2%
400,000
-26.4%
2.62%
-35.3%
NVST SellENVISTA HOLDINGS CORPORATION$14,613,000
-69.4%
300,000
-71.7%
1.74%
-73.9%
OHPAU SellORION ACQUISITION CORPunit 02/19/2026$9,815,000
-1.0%
999,513
-0.7%
1.17%
-15.5%
STXS SellSTEREOTAXIS INC$6,385,000
-43.6%
1,711,912
-6.3%
0.76%
-51.9%
LH ExitLABORATORY CORP AMER HLDGS$0-50,000
-100.0%
-2.19%
TMO ExitTHERMO FISHER SCIENTIFIC INC$0-24,000
-100.0%
-2.23%
AHCO ExitADAPTHEALTH CORP$0-700,000
-100.0%
-2.39%
CRL ExitCHARLES RIV LABS INTL INC$0-70,000
-100.0%
-3.68%
DVA ExitDAVITA INC$0-450,000
-100.0%
-7.13%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB LTD12Q3 20229.0%
GUARDANT HEALTH INC12Q3 20226.1%
CHARLES RIV LABS INTL INC11Q1 20237.8%
SURGERY PARTNERS INC11Q2 20236.4%
ICON PLC10Q3 202311.7%
BOSTON SCIENTIFIC CORP10Q3 20238.9%
NEVRO CORP10Q1 20226.7%
DEXCOM INC10Q3 20237.7%
ABBVIE INC9Q3 20238.1%
ACADIA HEALTHCARE COMPANY IN9Q3 20237.9%

View Iron Triangle Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Iron Triangle Partners LP's complete filings history.

Compare quarters

Export Iron Triangle Partners LP's holdings